Royal Bank of Canada (RBC) also reported a 48% increase in net income for its wealth-management division, reaching $980 ...

RBC Capital analyst Sean Dodge maintained a Buy rating on Teladoc (TDOC – Research Report) yesterday and set a price target of $12.00. The ...

Goldman Sachs analyst Oliver Carruthers maintained a Buy rating on London Stock Exchange (LSEG – Research Report) today and set a price target ...

Goldman Sachs reiterated its Buy rating on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shares with a steady price target of $78.00. The firm's analyst highlighted Ultragenyx's fourth-quarter total ...

The Goodman raising, the ASX’s sixth-largest ever and the bourse’s largest real estate deal, was done unsounded and with no ...

Royal Bank of Canada beat estimates on higher results in its capital-markets and wealth-management divisions as both units ...

Chinese authorities are rolling out fresh measures to limit capital flight, including increased scrutiny of overseas ...

Goldman Sachs is poised to benefit from an anticipated resurgence in capital markets activity. Analysts are optimistic about the company's prospects in this core area of its business, with several ...